Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD

Inclusion Criteria: * Ability to provide written informed consent and comply with study assessments for the full duration of the study. * Age \> 18 years * Clinical diagnosis of choroidal neovascularization secondary to the following causes: ocular histoplasmosis, toxoplasmosis, idiopathic, angioid streaks, choroidal ruptures, intraocular inflammation (without signs of active uveitis i.e. multifocal choroiditis), central serous retinopathy and pathologic Myopia. Only one eye will be assessed in the study. If both eyes are eligible, the investigator and patient will determine which eye is to be treated, considering such factors as disease duration, and likelihood of response to treatment. * Clear media and dilation to permit good stereo fundus photography * Evidence of active CNV present on OCT images manifest by subretinal fluid, intraretinal fluid or retinal thickening ≥ 250 µm * Best corrected VA in the study eye must be 20/40 and to 20/400 at 4 meters using ETDRS protocol. Exclusion Criteria: Pregnancy or lactation * Premenopausal women not using adequate contraception The following are considered effective means of contraception: surgical sterilization; use of oral contraceptives; barrier contraception with either a condom or diaphragm in conjunction with spermicidal gel; and IUD; or contraceptive hormone implant or patch. * CNV secondary to AMD * Diabetic Retinopathy * Prior enrollment in clinical studies in the study eye * Any other condition that the investigator…